BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koyama S, Koike N, Adachi S. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: A possible mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol. 2002;128:73-79. [PMID: 11862476 DOI: 10.1007/s004320100292] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Koyama S. Flow cytometric measurement of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J Gastroenterol Hepatol. 2003;18:763-770. [PMID: 12795746 DOI: 10.1046/j.1440-1746.2003.03055.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
2 Yun SM, Kim YS, Kim KH, Hur DY. Ampelopsin Induces DR5-Mediated Apoptotic Cell Death in EBV-Infected Cells through the p38 Pathway. Nutr Cancer 2020;72:489-94. [PMID: 31306050 DOI: 10.1080/01635581.2019.1639778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Fischer U, Ruckert C, Hubner B, Eckermann O, Binder V, Bakchoul T, Schuster FR, Merk S, Klein HU, Führer M, Dugas M, Borkhardt A. CD34+ gene expression profiling of individual children with very severe aplastic anemia indicates a pathogenic role of integrin receptors and the proapoptotic death ligand TRAIL. Haematologica 2012;97:1304-11. [PMID: 22315490 DOI: 10.3324/haematol.2011.056705] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
4 Carinci F, Monasta L, Rubini C, Stramazzotti D, Palmieri A, Melloni E, Knowles A, Ronfani L, Zauli G, Secchiero P. The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. Invest New Drugs 2012;30:810-8. [PMID: 21086019 DOI: 10.1007/s10637-010-9586-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Zhou W, Cao A, Wang L, Wu D. Kurarinone Synergizes TRAIL-Induced Apoptosis in Gastric Cancer Cells. Cell Biochem Biophys 2015;72:241-9. [DOI: 10.1007/s12013-014-0444-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
6 Koyama S. Coordinate cell-surface expression of matrix metalloproteinases and their inhibitors on cancer-associated myofibroblasts from malignant ascites in patients with gastric carcinoma. J Cancer Res Clin Oncol 2005;131:809-14. [PMID: 16180025 DOI: 10.1007/s00432-005-0030-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
7 Wang C, Xu S, Yi F, Wang X, Lei Y, Huang S, Zhou R, Xia B. Tumor Necrosis Factor-Related Apoptosis Inducing Ligand Gene Polymorphisms are Correlated with Gastric Cancer in Central China. Pharm Res 2015;32:762-8. [DOI: 10.1007/s11095-013-1217-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
8 Lane D, Robert V, Grondin R, Rancourt C, Piché A. Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells. Int J Cancer 2007;121:1227-37. [PMID: 17534891 DOI: 10.1002/ijc.22840] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 4.5] [Reference Citation Analysis]
9 Krieg A, Mersch S, Wolf N, Stoecklein NH, Verde PE, am Esch JS 2nd, Heikaus S, Gabbert HE, Knoefel WT, Mahotka C. Expression of TRAIL-splice variants in gastric carcinomas: identification of TRAIL-γ as a prognostic marker. BMC Cancer 2013;13:384. [PMID: 23937794 DOI: 10.1186/1471-2407-13-384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
10 De Voogd FA, Gearry RB, Mulder CJ, Day AS. Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma. J Gastroenterol Hepatol 2016;31:1386-92. [PMID: 26896745 DOI: 10.1111/jgh.13324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Secchiero P, Tiribelli M, Barbarotto E, Celeghini C, Michelutti A, Masolini P, Fanin R, Zauli G. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. J Cell Physiol. 2005;205:246-252. [PMID: 15887227 DOI: 10.1002/jcp.20392] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
12 Azijli K, van Roosmalen IA, Smit J, Pillai S, Fukushima M, de Jong S, Peters GJ, Bijnsdorp IV, Kruyt FA. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. Cancer Chemother Pharmacol 2014;73:1273-83. [PMID: 24744163 DOI: 10.1007/s00280-014-2465-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
13 Kimberley FC, Screaton GR. Following a TRAIL: update on a ligand and its five receptors. Cell Res 2004;14:359-72. [PMID: 15538968 DOI: 10.1038/sj.cr.7290236] [Cited by in Crossref: 165] [Cited by in F6Publishing: 151] [Article Influence: 9.7] [Reference Citation Analysis]
14 de Looff M, de Jong S, Kruyt FAE. Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy. Front Immunol 2019;10:1530. [PMID: 31333662 DOI: 10.3389/fimmu.2019.01530] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
15 Jutzy JM, Khan S, Asuncion-Valenzuela MM, Milford TA, Payne KJ, Wall NR. Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro. Cancer Microenviron 2013;6:57-68. [PMID: 22322461 DOI: 10.1007/s12307-012-0096-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
16 Davidson B. Malignant Nonhematological Effusion Characterization by Flow Cytometry. Acta Cytol 2016;60:365-71. [PMID: 27532128 DOI: 10.1159/000447687] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
17 Lane D, Matte I, Rancourt C, Piché A. The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer. J Ovarian Res 2010;3:1. [PMID: 20157422 DOI: 10.1186/1757-2215-3-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
18 Hussein M. Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight. Br J Dermatol 2005;153:18-21. [DOI: 10.1111/j.1365-2133.2005.06629.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
19 Ciummo SL, D'Antonio L, Sorrentino C, Fieni C, Lanuti P, Stassi G, Todaro M, Di Carlo E. The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs. Front Cell Dev Biol 2021;9:689286. [PMID: 34195201 DOI: 10.3389/fcell.2021.689286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chang-Qing F, Yi L, De-Guang W, Qing-Bin S, Xiang-Min H, Na T, Jian-Hua L. Immune clearance gastric carcinoma cells in ascites by activating caspase-9-induced apoptosis. APMIS 2011;119:173-9. [PMID: 21284734 DOI: 10.1111/j.1600-0463.2010.02707.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
21 Vigneswaran N, Baucum DC, Wu J, Lou Y, Bouquot J, Muller S, Zacharias W. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression. BMC Cancer 2007;7:108. [PMID: 17592646 DOI: 10.1186/1471-2407-7-108] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
22 Grimm M, Kim M, Rosenwald A, von Raden BH, Tsaur I, Meier E, Heemann U, Germer CT, Gasser M, Waaga-Gasser AM. Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer. Eur J Cancer. 2010;46:2314-2323. [PMID: 20580220 DOI: 10.1016/j.ejca.2010.05.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
23 Secchiero P, Gonelli A, Carnevale E, Corallini F, Rizzardi C, Zacchigna S, Melato M, Zauli G. Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand. Neoplasia 2004;6:364-73. [PMID: 15256058 DOI: 10.1593/neo.03421] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
24 Ikeguchi M, Oi K, Hirooka Y, Kaibara N. CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma. Eur J Surg Oncol. 2004;30:53-57. [PMID: 14736523 DOI: 10.1016/j.ejso.2003.10.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
25 Chen LH, Liu XS, Wang WY, Han WN, Pan BR, Jin BQ. Localization of TRAIL/TRAILR in fetal pancreas. World J Gastroenterol 2003; 9(2): 334-337 [PMID: 12532461 DOI: 10.3748/wjg.v9.i2.334] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
26 Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J. 2009;23:1625-1637. [PMID: 19141537 DOI: 10.1096/fj.08-111005] [Cited by in Crossref: 385] [Cited by in F6Publishing: 359] [Article Influence: 29.6] [Reference Citation Analysis]
27 Pei N, Jie F, Luo J, Wan R, Zhang Y, Chen X, Liang Z, Du H, Li A, Chen B, Zhang Y, Sumners C, Li J, Gu W, Li H. Gene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cells. PLoS One 2014;9:e92253. [PMID: 24658029 DOI: 10.1371/journal.pone.0092253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
28 Kimotsuki T, Tanaka K, Sugiura T, Koyama K, Nakamura T, Kamimura Y, Takasaki W, Manabe S. Thirteen-week Intravenous Toxicity Study of a Novel Humanized Anti-Human Death Receptor 5 Monoclonal Antibody, CS-1008, in Cynomolgus Monkeys. J Toxicol Pathol 2010;23:11-7. [PMID: 22272006 DOI: 10.1293/tox.23.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Sturm JW, Magdeburg R, Berger K, Petruch B, Samel S, Bönninghoff R, Keese M, Hafner M, Post S. Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer. 2003;107:11-21. [PMID: 12925951 DOI: 10.1002/ijc.11320] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
30 Derweesh IH, Tannenbaum CS, Rayman PA, Finke JH. Mechanisms of Immune Dysfunction in Renal Cell Carcinoma. In: Figlin RA, editor. Kidney Cancer. Boston: Springer US; 2003. pp. 29-51. [DOI: 10.1007/978-1-4615-0451-1_2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
31 Wei Q, Li M, Fu X, Tang R, Na Y, Jiang M, Li Y. Global analysis of differentially expressed genes in androgen-independent prostate cancer. Prostate Cancer Prostatic Dis 2007;10:167-74. [PMID: 17199135 DOI: 10.1038/sj.pcan.4500933] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
32 Färkkilä A, Zauli G, Haltia UM, Pihlajoki M, Unkila-Kallio L, Secchiero P, Heikinheimo M. Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential. Tumour Biol 2016;37:11909-16. [PMID: 27067438 DOI: 10.1007/s13277-016-5042-x] [Reference Citation Analysis]
33 Davidson B, Dong HP, Berner A, Risberg B, Layfield LJ. The diagnostic and research applications of flow cytometry in cytopathology. Diagn Cytopathol 2012;40:525-35. [DOI: 10.1002/dc.22809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
34 Hsu TS, Mo ST, Hsu PN, Lai MZ. c-FLIP is a target of the E3 ligase deltex1 in gastric cancer. Cell Death Dis 2018;9:135. [PMID: 29374180 DOI: 10.1038/s41419-017-0165-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
35 Deng C, Shao Z, Xiong X, Liu Z, Zhang Z. The expression of TRAIL and its receptors in osteosarcoma cells and the apoptosis effect of a combination of TRAIL, adriamycin and IFN-γ on MG-63 cells. Journal of Nanjing Medical University 2009;23:251-6. [DOI: 10.1016/s1007-4376(09)60065-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Liu GC, Zhang J, Liu SG, Gao R, Long ZF, Tao K, Ma YF. Detachment of esophageal carcinoma cells from extracellular matrix causes relocalization of death receptor 5 and apoptosis. World J Gastroenterol 2009; 15(7): 836-844 [PMID: 19230044 DOI: 10.3748/wjg.15.836] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
37 Ledig S, Wagner S, Manns MP, Beil W, Athmann C. Role of the receptor-mediated apoptosis in Helicobacter pylori in gastric epithelial cells. Digestion. 2004;70:178-186. [PMID: 15557763 DOI: 10.1159/000082252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
38 Ridolfi L, Petrini M, Fiammenghi L, Riccobon A, Ridolfi R. Human embryo immune escape mechanisms rediscovered by the tumor. Immunobiology. 2009;214:61-76. [PMID: 19159828 DOI: 10.1016/j.imbio.2008.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
39 Liu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, Wu YC, Chu Y, Chung FT, Kuo CH, Lee KY, Lin SM, Lin HC, Wang CH, Yu CT, Kuo HP. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J Cancer Res Clin Oncol 2010;136:35-45. [PMID: 19572148 DOI: 10.1007/s00432-009-0634-0] [Cited by in Crossref: 205] [Cited by in F6Publishing: 200] [Article Influence: 18.6] [Reference Citation Analysis]
40 Kursunel MA, Esendagli G. The untold story of IFN-γ in cancer biology. Cytokine & Growth Factor Reviews 2016;31:73-81. [DOI: 10.1016/j.cytogfr.2016.07.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]
41 Raval G, Biswas S, Rayman P, Biswas K, Sa G, Ghosh S, Thornton M, Hilston C, Das T, Bukowski R, Finke J, Tannenbaum CS. TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction. J Immunol 2007;178:6642-52. [PMID: 17475896 DOI: 10.4049/jimmunol.178.10.6642] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
42 Alderson KL, Murphy WJ. Antigen Specific Memory T Cells and Their Putative Need for the Generation of Sustained Anti-Tumor Responses. In: Zanetti M, Schoenberger SP, editors. Memory T Cells. New York: Springer; 2010. pp. 155-65. [DOI: 10.1007/978-1-4419-6451-9_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Yang J, Li G, Zhang K. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer. Biomed Pharmacother 2016;84:1078-87. [PMID: 27780136 DOI: 10.1016/j.biopha.2016.10.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
44 Bilski A, Pasz-Walczak G, Kubiak R, Sek P, Chalubinska J, Fendler W, Wronski K, Piekarska A, Pluta P, Potemski P, Jeziorski A, Piekarski J. TRAIL protein expression in breast cancer cells correlates with nuclear grade. Arch Med Sci 2010;6:545-51. [PMID: 22371798 DOI: 10.5114/aoms.2010.14466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]